SWM
IMUX icon

SHP Wealth Management’s Immunic IMUX Stock Holding History

SHP Wealth Management’s Portfolio IMUX Stock Details IMUX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$155 Buy
14
+9
+180% +$81 ﹤0.01% 1749
2025
Q4 		$27 Buy
+5
New +$37 ﹤0.01% 1540

Other funds holding IMUX

APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

SHP Wealth Management's IMUX Position: Q1 2026 in Review

SHP Wealth Management increased its Immunic (IMUX) stake by 180% in Q1 2026, buying an estimated $81 and bringing the position to 14 shares worth $155. The position accounts for ﹤0.01% of the portfolio, ranked #1749.

SHP Wealth Management first reported a position in IMUX in Q4 2025 and has held it in 2 quarters since. 75 funds tracked by Wall St. Rank hold IMUX as of Q1 2026.

  • SHP Wealth Management held 14 shares of Immunic worth $155 as of Q1 2026.
  • SHP Wealth Management bought 9 Immunic shares in Q1 2026, an estimated $81.
  • Immunic made up ﹤0.01% of SHP Wealth Management's portfolio in Q1 2026, its #1749 holding.
  • SHP Wealth Management first reported a position in Immunic in Q4 2025 and has held it in 2 quarters since.
  • 75 funds tracked by Wall St. Rank held Immunic as of Q1 2026.

Based on SHP Wealth Management's 13F filing for Q1 2026, filed 8 May 2026.